Momenta Pharmaceuticals, Inc. (MNTA)

[Regulardoc]

Given the amount of time the FDA has taken, supposedly reviewing MNTA's 40 mg petition, I have to doubt that they will rule on another company's 20 mg and 40 mg submission on the same date, as I doubt the reviews for the different dosages are running in lockstep.

Guess my question is why is the FDA taking so long for a unique generic that can save the public millions of dollars when they approve semi-worthless drugs such as Bonjesta which is comprised of OTC available products and " tamper resistant " narcotics such as Vantrela that have little to no purpose in the world of pharmaceuticals.

With each day passing with no approval, should one interpret this as more likely to be approved at anytime, or given no approval to date, is the 40 mg dose not approvable? Wonder if it could be the syringe. Anybody know if the 40 mg syringe has the same delivery characteristics as the 20 mg?